Oral GLP-1s may also provide more nuanced treatment regimens, such as combining the rapid weight loss of injectables maintaining a desired body weight with orals
The blog also explores injection site reactions, cardiovascular considerations, and dosing protocols, emphasizing the importance of quality standards in peptide research
Type 2 Diabetes (since 2009) Obesity treatment (since 2014) Cardiovascular outcomes and kidney trials ongoing Current research includes Alzheimers trials and other neurocognitive disorders | | Drug Examples: Liraglutide , Semaglutide | These GLP-1 receptor agonists are now being studied for their potential to cross the blood-brain barrier and exert neuroprotective effects, possibly mitigating oxidative stress and mitochondrial dysfunction associated with neurodegenerative diseases
Clinical Evidence and Future Directions Current Evidence Base The research specifically examining the combination of GLP-1 receptor agonists and glutathione is still emerging
And eating groats and greens, maybe even spicy groats and greens, may be able to provide an extra GLP-1 boost